FDA Drug Application (022544) for GRALISE by DEPOMED INC

Back to FDA Applications sponsored by DEPOMED INC

Application Number022544
Product Number001
FormTABLET;ORAL
Dosage300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code BX Drug products for which the data are insufficient to determine therapeutic equivalence
Reference Drug
Drug NameGRALISE
Active IngredientGABAPENTIN

Active IngredientCount
List of drugs with Active Ingredient GABAPENTIN3


Back to FDA Applications sponsored by DEPOMED INC